"10.1371_journal.pone.0031980","plos one","2012-02-29T00:00:00Z","Ulla Knorr; Maj Vinberg; Erik Lykke Mortensen; Per Winkel; Christian Gluud; JÃ¸rn Wetterslev; Ulrik Gether; Lars Vedel Kessing","Psychiatric Centre Copenhagen, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark; Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, University Hospital Copenhagen, Copenhagen, Denmark; Department of Health Psychology, University of Copenhagen, Copenhagen, Denmark; Department of Neuroscience and Pharmacology, Centre for Pharmacogenomics, University of Copenhagen, Copenhagen, Denmark","Conceived and designed the experiments: UK MV LVK CG JW UG. Performed the experiments: UK. Analyzed the data: PW UK LVK JW CG. Wrote the paper: UK. Revised drafts of the paper and final approval: UK MV ELM UG CG PW JW LVK.","The authors have read the journals policy and have the following conflicts: UK has been a paid speaker for Servier. MV has been a paid speaker for Eli Lilly, Jannsen-Cilag and AstraZeneca. LVK has been a consultant for Bristol-Myers Squibb, Eli Lilly, Lundbeck, AstraZeneca, Servier and Janssen-Cilag. The trial was fully investigator initiated and controlled to secure unbiased assessment of the effect of escitalopram on healthy first-degree relatives of patients with MD. ELM, UG, CG, PW, and JW declare no competing interests. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","02","Ulla Knorr","UK",8,FALSE,6,1,5,1,TRUE,TRUE,FALSE,0,NA,FALSE
